AIDS Reviews

Papers
(The TQCC of AIDS Reviews is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Lenacapavir Ó? a strong weapon to accelerate HIV prevention21
Central nervous system disorders in HIV-infected individuals using distinct antiretroviral drugs21
Mental Health Crisis in the Youth and Rebound in Sexually Transmitted Infections15
Beating HIV from day 1: strengthening same-day antiretroviral therapy in South Africa: challenges, realities, and the path forward15
The role of nurses in the prevention of anal cancer in HIV-infected men having sex with men – a focus on papillomavirus vaccination and anal cytology screening15
Obelisks Ó Newly discovered virus-like particles14
Global incidence of chlamydia infection and HIV pre-exposure prophylaxis13
Relationship between cytokine storm and SARS-CoV-2 infection’s worsening11
Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives10
Behavioral interventions for tobacco use in HIV-infected smokers: systematic review and pairwise, network meta-analysis of randomized trials10
Avian influenza in the context of a pandemic challenge10
Nutritional assessment in the HIV-infected older population receiving antiretroviral therapy10
International HTLV Conference, London, June 3-5, 20249
HIV-1 infection and the hematopoietic microenvironment9
Unraveling the complex interplay: HIV and male infertility9
Rapid antigen Testing and Mask Wearing While Waiting for COVID-19 Vaccines8
Evolution of Experimental Design and Research Techniques in HIV-1 Reservoir Studies: A Systematic Review7
Safety of Antiretroviral Therapy in the Treatment of HIV/AIDS in Children: Systematic Review and Meta-analysis6
Prevalence and risk factors for HIV infection in truck drivers: a systematic review of global evidence6
Research on differences in sexual orientation and identity6
Impact of New Coronavirus Epidemics on HIV-Infected Patients6
COVID-19 Comes 40 Years After AIDS – Any Lesson?5
Risk factors and mortality outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis5
The new profile of psychiatric disorders in patients with HIV infection5
The opioid epidemic during the COVID-19 pandemic: Impact on HIV and HCV control5
HTLV European Research Network 2023: the silent pandemic of HTLV-1 infection5
The impact of the M184V resistance mutation on treatment outcomes in patients with HIV infection: a systematic review and meta-analysis4
Mitochondrial damage as cause of long COVID4
Acquired syphilis in the context of pre-exposure prophylaxis for HIV: a systematic review of the scientific literature4
The management of polypharmacy in people living with HIV4
HIV-1 genotyping and drug resistance mutations in Morocco (2009-2024): a systematic review addressing critical gaps in molecular surveillance3
New SARS-CoV-2 Variants Challenge Vaccines Protection3
Rising in Listeria monocytogenes infection – any risk for persons living with HIV?3
Is SARS-CoV-2 the only cause of long-COVID?3
Humanized mouse models for preclinical evaluation of HIV cure strategies3
Adherence to antiretroviral therapy among HIV-1 patients from sub-Saharan Africa: a systematic review3
A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice3
HIV and liver disease3
Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era – Reflections Looking Forward3
Early and contemporary drivers of the HIV-1 group M pandemic3
The new face of advanced HIV infection3
Coinfection with Viral Hepatitis in HIV patients in 20233
0.026664972305298